Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies

H Alexopoulos, IP Trougakos, MA Dimopoulos… - European Journal of …, 2023 - Elsevier
In the COVID-19 pandemic era, antibody testing against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has proven an invaluable tool and herein we highlight some of …

Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination

HA Fryer, GE Hartley, ESJ Edwards… - Biochemical Society …, 2022 - portlandpress.com
Natural infection with SARS-CoV-2 induces a robust circulating memory B cell (Bmem)
population, which remains stable in number at least 8 months post-infection despite the …

Individuals with weaker antibody responses after booster immunization are prone to omicron breakthrough infections

B Möhlendick, I Čiučiulkaitė, C Elsner… - Frontiers in …, 2022 - frontiersin.org
Background Despite the high level of protection against severe COVID-19 provided by the
currently available vaccines some breakthrough infections occur. Until now, there is no …

[HTML][HTML] Neutralization of Omicron subvariants BA. 1 and BA. 5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort

M Itamochi, S Yazawa, N Inasaki, Y Saga, E Yamazaki… - Vaccine, 2023 - Elsevier
The sustained epidemic of Omicron subvariants of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a worldwide concern, and older adults are at high risk. We …

Increased secondary attack rates among the household contacts of patients with the Omicron variant of the coronavirus disease 2019 in Japan

T Ogata, H Tanaka, E Tanaka, N Osaki… - International Journal of …, 2022 - mdpi.com
This study investigated the household secondary attack rate (HSAR) of patients with
coronavirus disease (COVID-19) during the omicron variant-dominant period. The HSAR of …

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses

Q Li, L Zhang, Z Liang, N Wang, S Liu, T Li… - … and Targeted Therapy, 2022 - nature.com
A steep rise in Omicron reinfection cases suggests that this variant has increased immune
evasion ability. To evaluate its antigenicity relationship with other variants, antisera from …

Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose

L Perico, M Todeschini, F Casiraghi, M Mister… - Frontiers in …, 2023 - frontiersin.org
We examined the immune response in subjects previously infected with SARS-CoV2 and
infection-naïve 9 months after primary 2-dose COVID-19 mRNA vaccination and 3 months …

Real-world effectiveness of a booster dose of the COVID-19 vaccines among Japanese university students

S Miyauchi, T Hiyama, Y Nakano, M Yoshida… - Vaccines, 2022 - mdpi.com
With the spread of the Coronavirus disease 2019 (COVID-19), missing learning
opportunities due to COVID-19 has been raised as a major concern for university education …

Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge

EN Gary, NJ Tursi, BM Warner, G Cuismano… - Frontiers in …, 2023 - frontiersin.org
Despite numerous clinically available vaccines and therapeutics, aged patients remain at
increased risk for COVID-19 morbidity. Furthermore, various patient populations, including …

Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility

CM Trombetta, S Marchi, M Leonardi… - Human Vaccines & …, 2022 - Taylor & Francis
The SARS-CoV-2 pandemic has posed a challenge for correctional facilities worldwide.
People in such settings are more vulnerable to severe forms of infection and it is impossible …